“…Furthermore, these bacteria, as well as A. baumannii, are producers of a glycocalyx, that effects their adhesion to biomaterials such as polyvinylchloride, a common constituent of endotracheal tubes [11]. Treatment of nosocomial sinusitis is still controversial and may include removal of the nasal tubes, topical nasal decongestants, sinus drainage and lavage, and administration of systemic antibiotics based on susceptibility studies [2,[4][5][6]. Our findings suggest that patients with sinusitis due to S. aureus, A. baumannii and P. aeruginosa are at higher risk of developing pneumonia than those with sinusitis due to other pathogens.…”